Gilead Sciences

Vertex Pharmaceuticals

Amgen

Regeneron Pharmaceuticals

IQVIA Hlds

Alnylam Pharmaceuticals

Mettler-Toledo

Biogen

Illumina

Waters

iShares Nasdaq Biotechnology ETF

IBB tracks the performance of a modified market-cap-weighted index of US biotechnology companies listed on US exchanges.

Consensus is that the experts will find a vaccine to Covid-19 soon, so the biotech stocks have rallied hard. Buying them now carries risk.

Biotech Stocks Have Been on Fire, But Timing Is Everything

ARK Genomic Revolution Multi-Sector ETF

VanEck Vectors Biotech ETF

First Trust NYSE Arca Biotechnology Index Fund

SPDR S&P Biotech ETF

Novavax's latest progress in the Covid-19 vaccine development brings optimism to the Wall Street.

Biotech ETFs Soaring on COVID-19 Vaccine Progress

AstraZeneca

Loncar Cancer Immunotherapy ETF

With the race to find a vaccine for the coronavirus, now drugmaker AstraZeneca is the latest to receive funding to generate a panacea.

AstraZeneca Joins Coronavirus Vaccine Race, Great For Biotech ETFs

U.S. stocks are continuing to soar higher on Monday, moving into positive territory for May, following news that drugmaker Moderna released positive, preliminary results from the first human trial of its experimental Covid-19 vaccine, generating optimism that the medical community was taking steps to beat the coronavirus. Shares of the biotech company soared surged over [.

Biotech ETFs Climbing As Moderna Builds Hope For Coronavirus Vaccine

Positive data on early-stage coronavirus vaccine trial sent Moderna shares surging.

Moderna Soars: Biotech ETFs in Focus

Biotechnology-themed exchange-traded funds surged higher late Monday morning as investors rewarded pharmaceutical companies that looked likely to profit from treatments for COVID-19.

Biotech ETFs trade higher on upbeat coronavirus results

Invesco Dynamic Biotechnology & Genome ETF

The rising incidence of cancer cases has encouraged several major pharmaceutical and biotech players to invest substantially in the developments of drugs.

Biotech ETFs to Gain From Latest Advancements in Cancer Drugs

One options trader cashed out to the tune of $11 million after betting on biotech to surge. Now, they're wagering on an even bigger breakout.

This options trader won an $11 million bet on biotech. Now they're doubling down

Let's take a look at some ETFs with exposure to major players in the U.S. biotech industry, post their Q1 earnings releases amid the coronavirus crisis.

Are Biotech ETFs in Trouble as Coronavirus Dims Guidance?

Biotech funds have rallied within striking distance of multi-year resistance and could break out in coming weeks.

Biotech Funds Could Rally to New Highs

Rising investor interest in coronavirus related stocks will benefit these ETFs

Biotech ETFs Poised to Benefit From Coronavirus

If there is one area to watch should the stock market have another run up, it is the Biotechnology Sector NASDAQ: IBB. The channel lines that are perfectly parallel, go back to 2015.

The Beauty of the Biotechnology ETF (IBB) Price Channel

Invesco Dynamic Oil & Gas Services ETF

iShares MSCI Global Gold Miners ETF

VanEck Vectors Retail ETF

Sprott Gold Miners ETF

United States Oil Fund LP

InfraCap MLP

Energy, gold, online retail and biotech were the most-discussed ETF areas in April and could continue to be so in May.

Investor hope pushes biotech stocks to best monthly gain in two decades

As the coronavirus continues to spread, the latest positive data on remdesivir is some relief in such challenging times.

Biotech ETFs Gain on New Positive Data for Gilead's Remdesivir

Vanguard Health Care ETF

Health Care Select Sector SPDR Fund

The healthcare space is heated up with players rushing to come up with a vaccine for COVID-19.

Healthcare ETFs to Gain on Progress in Coronavirus Vaccine

iShares Genomics Immunology and Healthcare ETF

iShares U.S. Pharmaceuticals ETF

iShares U.S. Healthcare Providers ETF

Invesco DWA Healthcare Momentum ETF

ALPS Medical Breakthroughs ETF

SPDR S&P Health Care Services ETF

SPDR S&P Pharmaceuticals ETF

Biotech and healthcare ETFs were pretty stable on Apr 23 despite the news that Gilead's Remdesivir failed to improve Covid-19 patients' condition.

Healthcare & Biotech ETFs Digest GILD's Failure News: 5 Winners

Investors who were attaching their hopes for a swift end to the coronavirus pandemic to the antiviral medicine remdesivir from Gilead Sciences were disappointed, as Gilead released news Thursday that while the data suggests a “potential benefit,” the drug failed to increase the improvement of patients with COVID-19 or prevent them from dying, according to results [...]

Biotech ETFs Stable Despite Disappointing Treatment Date From Gilead

High daily death rates suggest a much more careful and measured reopening of the economy will be possible, not a quick-paced one.

Biotech Melt-Up

Invesco Dynamic Pharmaceuticals ETF

Coronavirus Sparked Healthcare ETFs In General, But Ultimately, We Really Do Need To Pick And Choose

Biotech stocks surged Friday after new details on a closely watched clinical trial lifted hopes that scientists may be close to a treatment for the coronavirus.

Biotech stocks surge as people are 'hungry' for good news on the coronavirus

iShares U.S. Medical Devices ETF

US healthcare has been a perennial underperformer, lagging the S&P 500 for five years, and underperforming 10% last year. This is now changing.

Investing In The Healthcare Turnaround

A Bear Turning Bull On IBB Based On Recent Developments

AbbVie

Bristol-Myers

Novartis

Pfizer

Drug developers took center stage as the world looks to these companies to deliver an answer to COVID-19.

4 Reasons Drug Stocks Are a Buy Right Now

While biotech stocks are often too risky for many investors, with the coronavirus raging and the race for a vaccine in play, taking a look at some ETFs that contain biotech stocks that are making strides might not be such a bad idea.

News for iShares Nasdaq Biotechnology ETF ETF (IBB)